Jeffrey Tobias

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations	2014	Jennifer S. Gewandter Robert H. Dworkin Dennis C. Turk Michael P. McDermott Ralf Baron Marc R. Gastonguay Ian Gilron Nathaniel P. Katz Cyrus R. Mehta Srinivasa N. Raja

Common Coauthors

Coauthor	Papers Together
Nathaniel P. Katz	1
Cristina Sampaio	1
Ian Gilron	1
Stephen Senn	1
Michael S. Leong	1
Karin L. Petersen	1
Charles Taylor	1
Christine Rauschkolb	1
Søren H. Sindrup	1
Marc R. Gastonguay	1
Richard L. Leff	1
Rolf‐Detlef Treede	1
Ralf Baron	1
Cyrus R. Mehta	1
David Hewitt	1
Paul J. Desjardins	1
Jonathan Stewart	1
Jennifer S. Gewandter	1
Robert D. Kerns	1
Robert H. Dworkin	1
Ilona Steigerwald	1
Eija Kalso	1
Gregory D. Jay	1
Joseph Stauffer	1
Raymond A. Dionne	1
Andrew S.C. Rice	1
John T. Farrar	1
Srinivasa N. Raja	1
Mark S. Wallace	1
Michael P. McDermott	1
Richard E. White	1
Smriti Iyengar	1
Dennis C. Turk	1
Penney Cowan	1
Michael C. Rowbotham	1
Rozalina Dimitrova	1
Bernard Ravina	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis.	2006	Michael Hubbert Hans‐Hinrich Sievers R Lehnfeld W. Kehrl	1
+	Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease	2010	Christine Micheel John R. Ball	1
+	The run-in period in clinical trials	1990	Erica Brittain Janet Wittes	1
+	Explanatory and Pragmatic Attitudes in Therapeutical Trials	2009	Daniel Schwartz J Lellouch	1
+	An examination of the efficiency of the sequential parallel design in psychiatric clinical trials	2007	Roy Tamura Xiaohong Huang	1
+	Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials	2007	Björn Bornkamp Frank Bretz Alex Dmitrienko Greg Enas Brenda Gaydos Chyi‐Hung Hsu Franz König Michael Krams Qing Liu Beat Neuenschwander	1
+	Implementation of a Bayesian adaptive design in a proof of concept study	2006	Michael K. Smith Ieuan Jones Mark Morris Andrew P. Grieve Keith Tan	1
+ PDF Chat	The Prevention and Treatment of Missing Data in Clinical Trials	2012	Roderick J. A. Little Ralph B. D’Agostino Michael L. Cohen Kay Dickersin Scott S. Emerson John T. Farrar Constantine Frangakis Joseph W. Hogan Geert Molenberghs Susan A. Murphy	1
+	Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group	2006	Paul Gallo Christy Chuang‐Stein Vladimir Dragalin Brenda Gaydos Michael Krams José Cirı́aco Pinheiro	1
+	N-of-1 Trials in the Medical Literature	2011	Nicole B. Gabler Naihua Duan Sunita Vohra Richard L. Kravitz	1
+	Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development	2009	Brenda Gaydos Keaven M. Anderson Donald A. Berry Nancy Burnham Christy Chuang‐Stein Jennifer Dudinak Parvin Fardipour Paul Gallo Sam Givens Roger Lewis	1
+ PDF Chat	Adaptive design methods in clinical trials – a review	2008	Shein‐Chung Chow Mark Chang	1
+	Enrichment of Clinical Study Populations	2010	Robert Temple	1
+	Diagnostics for confounding in PK/PD models for oxcarbazepine	2006	Jerry Nedelman Donald B. Rubin Lewis B. Sheiner	1
+	Mid‐course sample size modification in clinical trials based on the observed treatment effect	2003	Christopher Jennison Bruce W. Turnbull	1
+	Cross-Over Trials in Clinical Research	1994	Stephen Senn	1
+	Analysis of Nonrandomly Censored Ordered Categorical Longitudinal Data from Analgesic Trials	1997	Lewis B. Sheiner Stuart L. Beal Adrian Dunne	1
+	A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data	1994	L B Sheiner	1
+	Sample size re‐estimation in clinical trials	2009	Michael A. Proschan	1
+ PDF Chat	Addressing Missing Data in Clinical Trials	2011	Thomas R. Fleming	1
+	Optimal designs for estimating the most successful dose	2006	Sarah Zohar John O’Quigley	1
+	Bayesian clinical trials	2006	Donald A. Berry	1
+ PDF Chat	Dose Escalation Methods in Phase I Cancer Clinical Trials	2009	Christophe Le Tourneau J. Jack Lee Lillian L. Siu	1
+	Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response	2011	Hans‐Georg Eichler Éric Abadie Alasdair Breckenridge Bruno Flamion Lars L. Gustafsson Hubert G. M. Leufkens Malcolm Rowland Christian K. Schneider Brigitte Bloechl‐Daum	1
+	Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: Application to antidepressant trials	2012	Ruud Boessen Mirjam J. Knol Rolf H. H. Groenwold Diederick E. Grobbee Kit CB Roes	1
+	Threats to the Validity of Clinical Trials Employing Enrichment Strategies for Sample Selection	1998	P Leber Charles S. Davis	1
+	Statistical Issues in Drug Development	2021	Stephen Senn	1
+ PDF Chat	Adaptive dose finding based on <i>t</i>‐statistic for dose–response trials	2008	Anastasia Ivanova James A. Bolognese Inna Perevozskaya	1
+ PDF Chat	The design and conduct of clinical trials to limit missing data	2012	Roderick J. A. Little Matthew L. Cohen Kay Dickersin Scott S. Emerson John T. Farrar James D. Neaton Weichung Joe Shih Jay P. Siegel Hal S. Stern	1
+	A comprehensive algorithm for determining whether a run‐in strategy will be a cost‐effective design modification in a randomized clinical trial	1993	Kenneth B. Schechtman Mae E. Gordon	1
+	Improvement of phase III psychotropic drug trials by intensive phase II work.	1991	D F Klein	1
+	Adaptive Designs: Terminology and Classification	2006	Vladimir Dragalin	1